{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:46:05Z","timestamp":1792107965410,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41390-025-04742-2","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:27:22Z","timestamp":1767947242000},"page":"1091-1099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of cystatin C for chronic kidney disease in pediatric urologic malformations"],"prefix":"10.1038","volume":"100","author":[{"given":"Shu-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hao","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hsing","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"4742_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1700993","volume":"378","author":"R Calderon-Margalit","year":"2018","unstructured":"Calderon-Margalit, R. et al. History of childhood kidney disease and risk of adult end-stage renal disease. N. Engl. J. Med. 378, 428\u2013438 (2018).","journal-title":"N. Engl. J. Med."},{"key":"4742_CR2","doi-asserted-by":"publisher","first-page":"e2231626","DOI":"10.1001\/jamanetworkopen.2022.31626","volume":"5","author":"T Hays","year":"2022","unstructured":"Hays, T. et al. The prevalence and clinical significance of congenital anomalies of the kidney and urinary tract in preterm infants. JAMA Netw. Open 5, e2231626 (2022).","journal-title":"JAMA Netw. Open"},{"key":"4742_CR3","doi-asserted-by":"publisher","first-page":"e0323257","DOI":"10.1371\/journal.pone.0323257","volume":"20","author":"M Raina","year":"2025","unstructured":"Raina, M. et al. The global health burden of pediatric chronic kidney disease: an analysis of the Global Burden of Disease Database from 1990 to 2021. PLoS One 20, e0323257 (2025).","journal-title":"PLoS One"},{"key":"4742_CR4","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1515\/cclm-2012-0257","volume":"50","author":"G Filler","year":"2012","unstructured":"Filler, G., Huang, S. H. & Yasin, A. The usefulness of Cystatin C and related formulae in pediatrics. Clin. Chem. Lab. Med. 50, 2081\u20132091 (2012).","journal-title":"Clin. Chem. Lab. Med."},{"key":"4742_CR5","doi-asserted-by":"publisher","first-page":"e2238300","DOI":"10.1001\/jamanetworkopen.2022.38300","volume":"5","author":"JS Lees","year":"2022","unstructured":"Lees, J. S. et al. Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Netw. Open 5, e2238300 (2022).","journal-title":"JAMA Netw. Open"},{"key":"4742_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","volume":"369","author":"MG Shlipak","year":"2013","unstructured":"Shlipak, M. G. et al. Cystatin C Versus Creatinine in determining risk based on kidney function. N. Engl. J. Med 369, 932\u2013943 (2013).","journal-title":"N. Engl. J. Med"},{"key":"4742_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/apa.15538","volume":"110","author":"Y Kandasamy","year":"2021","unstructured":"Kandasamy, Y. & Rudd, D. Cystatin C: A more reliable biomarker of renal function in young infants? A longitudinal cohort study. Acta Paediatr. 110, 1341\u20131345 (2021).","journal-title":"Acta Paediatr."},{"key":"4742_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0022-5347(05)00015-7","volume":"175","author":"AM Corrao","year":"2006","unstructured":"Corrao, A. M. et al. Serum Cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations. J. Urol. 175, 303\u2013309 (2006).","journal-title":"J. Urol."},{"key":"4742_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fped.2019.00182","volume":"7","author":"CP Katsoufis","year":"2019","unstructured":"Katsoufis, C. P. et al. Risk assessment of severe Congenital Anomalies of the Kidney and Urinary Tract (Cakut): a birth cohort. Front Pediatr. 7, 182 (2019).","journal-title":"Front Pediatr."},{"key":"4742_CR10","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00520-017-4002-3","volume":"26","author":"P Whiting","year":"2018","unstructured":"Whiting, P. et al. Accuracy of Cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data. Support Care Cancer 26, 1635\u20131644 (2018).","journal-title":"Support Care Cancer"},{"key":"4742_CR11","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes, C. K. D. W. G","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes, C. K. D. W. G Kdigo 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 105, S117\u2013S314 (2024).","journal-title":"Kidney Int"},{"key":"4742_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s004670050419","volume":"12","author":"A Bokenkamp","year":"1998","unstructured":"Bokenkamp, A., Domanetzki, M., Zinck, R., Schumann, G. & Brodehl, J. Reference Values for Cystatin C serum concentrations in children. Pediatr. Nephrol. 12, 125\u2013129 (1998).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","volume":"115","author":"JH Ix","year":"2007","unstructured":"Ix, J. H., Shlipak, M. G., Chertow, G. M. & Whooley, M. A. Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115, 173\u2013179 (2007).","journal-title":"Circulation"},{"key":"4742_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1053\/j.ajkd.2022.02.018","volume":"80","author":"U Nyman","year":"2022","unstructured":"Nyman, U. et al. The Modified CKD study estimated gfr equations for children and young adults under 25 years of age: performance in a European multicenter cohort. Am. J. Kidney Dis. 80, 807\u2013810 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"4742_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jpurol.2013.08.010","volume":"10","author":"S Yavuz","year":"2014","unstructured":"Yavuz, S., Anarat, A. & Bayazit, A. K. Assessment of Cystatin C and Cystatin C-Based GFR Formulas in Reflux Nephropathy. J. Pediatr. Urol. 10, 262\u2013267 (2014).","journal-title":"J. Pediatr. Urol."},{"key":"4742_CR16","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00467-017-3733-1","volume":"32","author":"S Tomotaki","year":"2017","unstructured":"Tomotaki, S., Toyoshima, K., Shimokaze, T., Shibasaki, J. & Nagafuchi, H. Association between Cord Blood Cystatin C levels and early mortality of neonates with congenital abnormalities of the kidney and urinary tract: a single-center, retrospective cohort study. Pediatr. Nephrol. 32, 2089\u20132095 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR17","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1097\/01.ju.0000060205.23406.13","volume":"169","author":"A Pham-Huy","year":"2003","unstructured":"Pham-Huy, A., Leonard, M., Lepage, N., Halton, J. & Filler, G. Measuring glomerular filtration rate with Cystatin C and beta-trace protein in children with Spina Bifida. J. Urol. 169, 2312\u20132315 (2003).","journal-title":"J. Urol."},{"key":"4742_CR18","first-page":"182","volume":"7","author":"CL Abitbol","year":"2020","unstructured":"Abitbol, C. L. & S. W. G. M. G Neonatal Cystatin C and early progression to advanced chronic kidney disease in severe congenital anomalies of the kidney and urinary tract. Front Pediatr. 7, 182 (2020).","journal-title":"Front Pediatr."},{"key":"4742_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.ajkd.2021.05.018","volume":"79","author":"HU Zacharias","year":"2022","unstructured":"Zacharias, H. U. et al. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests. Am. J. Kidney Dis. 79, 217\u2013230 e211 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"4742_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/cc5923","volume":"11","author":"JD Herrero-Morin","year":"2007","unstructured":"Herrero-Morin, J. D. et al. Cystatin C and Beta2-Microglobulin: markers of glomerular filtration in critically ill children. Crit. Care 11, R59 (2007).","journal-title":"Crit. Care"},{"key":"4742_CR21","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00467-024-06316-6","volume":"39","author":"H Pizzo","year":"2024","unstructured":"Pizzo, H. et al. Comparison of estimated GFR using Cystatin C versus creatinine in pediatric kidney transplant recipients. Pediatr. Nephrol. 39, 2177\u20132186 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.clinbiochem.2006.10.026","volume":"40","author":"JF Roos","year":"2007","unstructured":"Roos, J. F., Doust, J., Tett, S. E. & Kirkpatrick, C. M. Diagnostic accuracy of Cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin. Biochem. 40, 383\u2013391 (2007).","journal-title":"Clin. Biochem."},{"key":"4742_CR23","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00467-020-04877-w","volume":"36","author":"A Stankovic","year":"2021","unstructured":"Stankovic, A. Promising biomarkers in pediatric chronic kidney disease through the kaleidoscope of Cakut background complexity. Pediatr. Nephrol. 36, 1321\u20131325 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00467-012-2341-3","volume":"28","author":"EJ Nehus","year":"2013","unstructured":"Nehus, E. J., Laskin, B. L., Kathman, T. I. & Bissler, J. J. Performance of Cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatr. Nephrol. 28, 453\u2013461 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR25","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00467-020-04612-5","volume":"35","author":"T Cai","year":"2020","unstructured":"Cai, T. et al. Reference intervals for serum Cystatin C in neonates and children 30 days to 18 years old. Pediatr. Nephrol. 35, 1959\u20131966 (2020).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00467-015-3309-x","volume":"31","author":"T Nakashima","year":"2016","unstructured":"Nakashima, T., Inoue, H., Fujiyoshi, J. & Matsumoto, N. Longitudinal analysis of serum Cystatin C for estimating the glomerular filtration rate in preterm infants. Pediatr. Nephrol. 31, 983\u2013989 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"4742_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00467-021-05209-2","volume":"37","author":"N Ziegelasch","year":"2022","unstructured":"Ziegelasch, N. et al. Cystatin C relates to metabolism in healthy, pubertal adolescents. Pediatr. Nephrol. 37, 423\u2013432 (2022).","journal-title":"Pediatr. Nephrol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04742-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:56:54Z","timestamp":1792105014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04742-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4742"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04742-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Regarding ethical approval, per the TriNetX publication guidelines \u201cThis retrospective study is exempt from informed consent. The data reviewed is a secondary analysis of existing data, does not involve intervention or interaction with human subjects, and is de-identified per the de-identification standard defined in Section \u00a7164.514(a) of the HIPAA Privacy Rule. The process by which the data is de-identified is attested to through a formal determination by a qualified expert as defined in Section \u00a7164.514(b)(1) of the HIPAA Privacy Rule. This formal determination by a qualified expert was refreshed on December 2020.\u201d (\n                      \n                      , accessed January 12, 2025).","order":2,"name":"Ethics","label":"Consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}